Accessibility settings

This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (5189) Clinical Information and Decision Making (3749)

Published on in Vol 6, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30577, first published .
Elderly man in a beige sweater using a smartphone on a couch.

A Free Open-Source Bayesian Vancomycin Dosing App for Adults: Design and Evaluation Study

A Free Open-Source Bayesian Vancomycin Dosing App for Adults: Design and Evaluation Study

Authors of this article:

Thomas Oommen1 Author Orcid Image ;   Anirudh Thommandram2 Author Orcid Image ;   Adam Palanica2 Author Orcid Image ;   Yan Fossat2 Author Orcid Image
Article Authors Cited by (10) Tweetations (3) Metrics

Journals

  1. Salam M, Nguyen C, Knoebel R, Pettit N. Practical Challenges With the Implementation of First-Order Pharmacokinetic Analytic Equations for AUC Monitoring for Vancomycin. Annals of Pharmacotherapy 2023;57(8):997 View
  2. Mena M, Garcia J, Bustos R. Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients. Antibiotics 2023;12(2):301 View
  3. Kim D, Choi H, Lee D, Kim M, Kim Y, Han S, Heo Y, Park J, Park J. A Deep Learning–Based Approach for Prediction of Vancomycin Treatment Monitoring: Retrospective Study Among Patients With Critical Illness. JMIR Formative Research 2024;8:e45202 View
  4. Matava C, Bordini M, Jasudavisius A, Santos C, Caldeira-Kulbakas M. Comparing the Effectiveness of a Clinical Decision Support Tool in Reducing Pediatric Opioid Dose Calculation Errors: PediPain App vs. Traditional Calculators – A Simulation-Based Randomised Controlled Study. Journal of Medical Systems 2024;48(1) View
  5. Limelette A, Tromeur T, Rhaiem R, Bonnet M, N'Guyen Y. No Impact of Vancomycin MIC, AUC, or AUC/MIC in Enterococcus faecium Bacteremia. Fundamental & Clinical Pharmacology 2025;39(5) View
  6. Serban A, Baracan A, Mitrica M, Dima L. Vancomycin Therapy Monitoring—The Gaps Between Guidelines and Clinical Practice. American Journal of Therapeutics 2025;32(5):e467 View
  7. Holub L, Karvaly G, Závorszky L, Kristóf K, Tóth Á, Tóth K, Lovász B, Kassa C, Vásárhelyi B, Lakatos B, Szabó B. Felnőtt betegek farmakokinetikai-farmakodinamikai célértékek segítségével vezérelt intravénás kezelése vankomicinnel. Orvosi Hetilap 2025;166(17):638 View
  8. Song X, Zeng M, Yang T, Han M. Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities. Pharmacology Research & Perspectives 2026;14(1) View
  9. Belyavsky N. THE VANCOMYCIN USE PECULIARITIES IN COMPLEX THERAPY FOR SEPSIS COMBINED WITH THE APPLICATION OF SORPTION METHODS OF EXTRACORPOREAL DETOXIFICATION. Vestnik of Vitebsk State Medical University 2024;23(2):35 View
  10. Berdnikova N, Tsyganko D, Vasiukov V, Arnautov V, Trofimov A, Menshov V, Melnikov E, Shikh E, Sologova S, Smolyarchuk E, Lazareva N. Therapeutic Monitoring of Vancomycin and Factors Affecting Survival in ICU Patients with Infections. Pharmaceuticals 2026;19(8):1303 View